A drug company head says the government should hold an inquiry into the prices pharmaceutical firms charge for breast cancer drugs. Patients battling for two new drugs had their calls for an inquiry into drug-buyer Pharmac turned down by MPs last week. …
Roche Holding AG (OTCQX:RHHBY) Q1 2019 Results Earnings Conference Call April 17, 2019 8:00 AM ET Company Participants Severin Schwan - CEO, Roche Group Bill Anderson - CEO, Roche Pharmaceuticals Michael Heuer - CEO Roche Diagnostics Alan Hippe - Chief …
The long-anticipated slowdown of Roche as its ‘big three’ antibody drugs face biosimilar competition still hasn’t arrived, with new product sales offsetting the declines in the first quarter. There was some slippage for immunology drug MabThera/Rituxan …
ZURICH (Reuters) - Swiss drugmaker Roche lifted its 2019 outlook on Wednesday, as sales growth in China and the United States outpaced price declines it has suffered amid President Donald Trump’s pressure on the industry to hold down charges. FILE PHOTO: …
Rupali.Mukherjee | TNN Mumbai: Ahmedabad-based Intas Pharmaceuticals is launching a life-saving breast cancer drug, trastuzumab biosimilar, at Rs 19,995 (per 440 mg vial) — priced 65% lower than the existing MRP of major brands. The development, say …
Pfizer Inc. announced the European Commission (EC) has approved Zirabev for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectable advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), advanced …
Breast cancer is the most common invasive cancer in women, and the second main cause of cancer death in women, after lung cancer.Advances in screening and treatment have improved survival rates dramatically since 1989. There are around 3.1 million breast …
ZURICH/MUNICH (Reuters) - An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines …
ZURICH/MUNICH: An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals. Trial data …
* Data shows Tecentriq helped breast cancer patients * Survival data is immature, but Roche optimistic * Trailing rivals, Roche seeking immunotherapy niches (Adds comments from lead study author, details on PD-L1 subgroup) By John Miller and Ludwig Burger …
(Corrects first name of Roche Chief Medical Officer in third paragraph) * Data shows Tecentriq helped breast cancer patients * Survival data is immature, but Roche optimistic * Trailing rivals, Roche seeking immunotherapy niches By John Miller and Ludwig …
Vascular Biogenics Ltd. (NASDAQ:VBLT) Q4 2018 Results Conference Call March 28, 2019 8:30 AM ET Company Participants Michael Wood - LifeSci Advisors Dror Harats - CEO Amos Ron - CFO Erez Feige - VP of Business Operations Conference Call Participants …
Development of Phase 3 product candidate VB-111 continues in ovarian cancer toward interim analysis at year-end 2019 and expands through investigator-sponsored trials in rGBM and colon cancer Signed strategic agreement for VB-201 for veterinary use; …
Radiologists look at a scan of a breast tumor. Methods to look at a tumor in real-time may soon be able to help surgeons to more accurately remove tumors and preserve healthy tissue. Photo credit: Getty Royalty Free. Researchers in The Netherlands have …
Roche announced that the US Food and Drug Administration (FDA) approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of adults with extensive-stage small cell lung cancer (ES …
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 18, 2019--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab), in combination with …
Shares of Infinity Pharmaceuticals Inc. (INFI - Free Report) rose almost 24% after the company announced that it has entered into a master clinical supply agreement with Roche (RHHBY - Free Report) . Per the deal, Roche will supply Tecentriq (atezolizumab …
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Q4 2018 Results Earnings Conference Call March 14, 2019 8:00 AM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Samuel Agresta - CMO Lawrence Bloch - President Jeffery …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please …
Oncology specialist Dr. Eugenio Galindo provides professional insight into common breast cancer risk factors in the United States. MISSION, TEXAS, USA, April 16, 2019 /EINPresswire.com/ -- Cancer which forms in the cells of the breasts, breast …
WESTPORT, Conn., April 17, 2019 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary therapeutic agents, …
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
Have an event? Add it to our Events & Conferences Directory.
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/21/2019
JURAVIN RESEARCH found "natural" or "fresh" orange juice to be very fattening, with NO HEALTH BENEFITS, and an expensive price: 250% more than other drinks. ORLANDO, FLORIDA, UNITED STATES, April 19, 2019 /EINPresswire.com/ …
SEATTLE, WASHINGTON, USA, April 19, 2019 /EINPresswire.com/ -- For decades, Dr. Gregory Jantz has studied hundreds of patient disorders to help them arrive at a healthy resolution using his unique approach to care. Through whole-person care, …
Specialist behavioral expert Rocio Moustafa takes a closer look at the condition known as antisocial personality disorder. VENTURA, CALIFORNIA, USA, April 19, 2019 /EINPresswire.com/ -- With more than 200,000 cases diagnosed in the United States …
Healthcare mergers are becoming ever more popular. Himachal Mukhopadhyay discusses some of the top mergers of 2018. ROSEVILLE, CALIFORNIA, USA, April 19, 2019 /EINPresswire.com/ -- While we might one quarter of the way through the new year …
Urology specialist Cletus Roy Georges, MD reveals more about stress urinary incontinence and the associated condition known as 'overactive bladder.' ORLANDO, FLORIDA, USA, April 19, 2019 /EINPresswire.com/ -- Stress urinary …
NaVOBA and the NBIC share symbiotic goals to advocate for the business interests of a diverse range of people in Corporate America's inclusion initiatives. PITTSBURGH, PA, USA, April 19, 2019 /EINPresswire.com/ -- ECONOMIC NEWS: Veteran …
The Diabetes Care Devices Market from The Business Research Company, offers a sales Strategies, growth analysis, size, segmentation, forecast and much more. LONDON, GREATER LONDON, UK, April 19, 2019 /EINPresswire.com/ -- The market for diabetes …
SC RegenCare now offering state-of-the-art ESWT to treat ED CHARLESTON, SC, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- ESWT (Extracorporeal Smart Wave Therapy) uses energy from acoustic sound waves to stimulate blood vessel growth …
Veterinary Pharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Veterinary Pharmaceuticals Industry Description Wiseguyreports. …
CONROE, TEXAS, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- Every day a new threat to your health and safety is announced in the media--like the recall of turkey products tainted by salmonella, a new strain of antibiotic resistant bacteria …
MORRISVILLE, VERMONT, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- The ancient art of Palmistry dates back to ancient Greece and Aristotle and was widely used throughout empires and nations. Today many of us battle with relationship …
Pharma Excipients -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Pharma Excipients Industry Description Wiseguyreports.Com Adds “Pharma …
Superabrasives -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Superabrasives Industry Description Wiseguyreports.Com Adds “Superabrasives …
Energy Nutrition Bars -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024 PUNE, MAHARASHTRA, INDIA, April 19, 2019 /EINPresswire.com/ -- Energy Nutrition Bars Industry Description Wiseguyreports.Com Adds “ …
The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, is …
Santhigram Kerala Ayurveda opens its Premium Ayurvedic Hospital at Gurugram, NCR Delhi, India NEW DELHI, DELHI, INDIA, April 19, 2019 /EINPresswire.com/ -- Santhigram Kerala Ayurveda opens its Premium Ayurvedic Hospital at Gurugram, NCR Delhi, …
ITFirms goes for balance in its hunt for top e-commerce development companies'19! NEW YORK, UNITED STATES, April 19, 2019 /EINPresswire.com/ -- According to Michael Leboeuf, a satisfied customer is the best business strategy of all. Success …
FORT COLLINS, Colo., April 19, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully leveraged a robust intellectual property portfolio by applying patented drug delivery system technologies to cannabinoid formulations …
Download logo Three IRC staff caught up in attack that led to tragic loss of life of an Ebola Response staff member; IRC stands with the community and sister organizations in mourning this attack; To date more than 1,290 people have contracted Ebola since …
The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose. The agency is also …
Welcome to EIN Newsdesk
Millions of professionals find us an indispensable source for
breaking news. Basic accounts are FREE.
Sources
We scan thousands of news sites, so you don't have to, saving
you time and money.
Topics
We are similar to Google News but focus on news tracking by country,
industry and topic, so you don't miss any important news
that affects your company, organization or interest.
Custom News
Any news page or search results can be turned into an email news alert
or live RSS feed. You can share relevant news on your website,
intranet, workgroup or mobile device.
News Alert Maker
It's a one-stop destination for all your alerts and feeds.
Manage your media monitoring in one secure location.
Relevant. Time-Saving. Free.
And so easy to use. Check out our short video and
check in with us to start right now.
Get Started
Join millions of professionals in business, industry, and government who
have relied on EIN News since 1995.
